Iprindole

This classification denotes a tricyclic antidepressant with the molecular formula C19H28N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 69U0IKR8FP, chemically known as 5h-cyclooct(b)indole-5-propanamine, 6,7,8,9,10,11-hexahydro-n,n-dimethyl- but generally known as iprindole, which bears US NIH Compound Identifier 21722. European Medicines Agency schedules Iprindole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08279MIG. World Health Organization schedules iprindole in its Anatomical Therapeutic Chemical (ATC) Classification. IPRINDOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule iprindole under HS 29339990 and SITC 51577. As of Q4 2014, IPRINDOLE remains the US FDA Preferred Term for this commodity. SMILES: n1(c2c(CCCCCC2)c2c1cccc2)CCCN(C)C.